The expression levels of inflammatory cytokines and chemokines (e.g., TNFα, IL-6, CXCL1, CXCL2, CXCR2, CCL2) in crush syndrome were significantly suppressed in TPEN-treated group (Fig. 3i). Here, CXCR2 is linked to Crush Syndrome.